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Original Article
Smoking Raises the Risk of Total and Ischemic Strokes
in Hypertensive Men
Kazumasa YAMAGISHI＊, Hiroyasu ISO＊, Akihiko KITAMURA＊＊, Tomoko SANKAI＊,＊＊＊,
Takeshi TANIGAWA＊, Yoshihiko NAITO＊＊, Shinichi SATO＊＊, Hironori IMANO＊＊, 
Tetsuya OHIRA＊＊, and Takashi SHIMAMOTO＊＊
To examine the relation between cigarette smoking and risk of stroke and coronary heart disease among
Japanese, we conducted a 14-year prospective study of 3,626 men aged 40–69, initially free from history of
stroke and coronary heart disease. We identified 257 strokes (75 hemorrhagic and 173 ischemic strokes)
and 100 coronary heart disease events. When we adjusted for age and other cardiovascular risk factors, a
significant excess risk among current smokers of ＞20 cigarettes/day vs. never-smokers was found for total
stroke (relative risk (RR)＝1.6 (95% confidence interval (CI), 1.1–2.4)). The excess risk of total stroke was
particularly evident among hypertensives (RR＝2.3 (1.2–4.4)). The multivariate RR of ischemic stroke was 1.6
(1.0–2.5) for total subjects, and 2.2 (1.0–5.0) among hypertensives. Significant excess risks among current
smokers of ＞20 cigarettes/day vs. never-smokers were also found for coronary heart disease (RR＝4.6
(1.6–12.9)) and total cardiovascular disease (1.9 (1.3–2.7)). The estimated proportion of the events attribut-
able to current smoking was 30 (95% CI, 11–44)% for total stroke and 34 (5–54)% for coronary heart disease.
In conclusion, current smoking of ＞20 cigarettes per day increased the risk of both total stroke and is-
chemic stroke among Japanese middle-aged men, and particularly among middle-aged hypertensive men.
(Hypertens Res 2003; 26: 209–217)
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tion between smoking and risk of total stroke was reported in
a 7.7-years follow-up study of 6,359 Japanese white-collar
workers aged 35–59 years, but the number of incidents of
stroke was only 33 (10). A 13-year follow-up study of over
120,000 men showed a 30% higher age-adjusted mortality
from total stroke and a 70% higher mortality from subarach-
noid hemorrhage associated with smoking, but no excess
mortality from ischemic stroke (5). Another 14-year follow-
up study of 40,861 Japanese men showed a significant asso-
ciation between smoking and age-adjusted mortality from to-
tal stroke (11). These two studies, however, did not present
multivariate relative risks adjusting for potential confound-
ing factors. Moreover, mortality data on stroke are of limited
value in identifying the etiologic role of smoking, because
Introduction
Japan has a high prevalence of smoking for men and a low
prevalence for women: the respective prevalences were
54.0% and 14.5% in 1999, although the prevalence of smok-
ing for men has decreased since 1965 (1). There is limited
evidence that smoking increases the risk of stroke in Japa-
nese populations, whereas the relation between smoking and
risk of coronary heart disease has been consistently reported
(2–6). Previous Japanese cohort studies of approximately
1,000 to 8,000 individuals did not find any significant rela-
tionship between cigarette smoking and risks of total or is-
chemic stroke (7–9). On the other hand, a significant associa-
one-third of fatal strokes do not appear as the underlying
cause of death (12).
We postulated that the lack or weakness of association be-
tween smoking and risks of stroke in most previous Japanese
studies, in contrast to Caucasian studies, is due in part to the
different proportions of ischemic stroke subtypes (lacunar in-
farction and large-artery occlusive infarction) between
Japanese and Caucasians, a low statistical power to detect
significant associations, and a lower concern for hyperten-
sion, a strong cardiovascular risk factor (13). We hypothe-
sized that smoking raises the risk of total stroke, ischemic
stroke, and coronary heart disease among middle-aged
Japanese men, and that these trends are more evident among
hypertensive men. Then, we used data from a long-term fol-
low-up study of 3,626 men in three Japanese populations to
investigate the relationship between smoking and risk of
stroke and its subtypes as well as coronary heart disease.
Methods
Populations
The population surveyed included 3,754 men aged 40–69
years examined between 1975 and 1980 in Ikawa, a north-
eastern rural community, between 1981 and 1986 in Kyowa,
a mid-eastern rural community, and between 1975 and 1984
in the district of Yao City, a mid-western community. The
overall participation rate was 63%. Persons who did not pro-
vide information on their smoking status (n＝7) or persons
with a history of stroke and/or coronary heart disease
(n＝121) were not entered into our study. Thus, data from a
total of 3,626 men were used for the analyses. We excluded
women from this analysis because women rarely smoke in
Japan; the prevalence of current smokers in our cohort was
only 8% in women compared with 69% in men. Subjects
were followed-up to determine cardiovascular disease end-
points occurring by the end of 1997. The number of persons
who moved out of the communities during the follow-up was
177 (5%) and that of persons who died was 709 (20%). They
were censored at the date of moving out or the date of death.
The average follow-up period was 14.3 years.
Surveillance of Incident Cardiovascular Disease
Participant follow-up included annual cardiovascular risk
surveys to obtain histories of incident stroke and coronary
heart disease and neurological examinations by the study
physicians. For those patients who did not participate in the
follow-up examinations, strokes were ascertained by mailed
questionnaires, national insurance claims, ambulance
records, reports by local physicians, and reports by public
health nurses and health volunteers (14). From death certifi-
cates, cases with stroke as an underlying cause of death (In-
ternational Statistical Classification of Diseases and Related
Health Problems (ICD) 9 classification: stroke, 430–438;
coronary heart disease, 410–414, 428 and 429) were selected
and histories were obtained from their families. To confirm
the diagnosis, all living patients were visited or called and
their medical histories were taken by study physicians or
public health nurses. Then, we reviewed the medical records,
including ECG and CT and/or MRI films, for both non-fatal
and fatal cases.
Stroke was defined as a rapid-onset focal neurological dis-
order persisting for ≥24 h, or until death. Transient is-
chemic attack was not included. The stroke subtype, i.e., in-
traparenchymal hemorrhage, subarachnoid hemorrhage, or
ischemic stroke, was determined primarily by CT or MRI us-
ing standardized criteria (15). Stroke cases that were diag-
nosed clinically but showed no lesion on CT or MRI were
classified as ischemic stroke. The CT or MRI films were
available for 75% of the stroke cases. Stroke cases without
CT or MRI films were classified according to the clinical cri-
teria (16) based on the criteria of Millikan (17). Previous
studies have confirmed the validity of stroke subtype classifi-
cation by clinical criteria (18).
The criteria for coronary heart disease were modified from
those of a WHO Expert Committee (19). Painless types of
coronary heart disease were not investigated because of the
difficulty of making a definite diagnosis. Definite myocardial
infarction was indicated by typical chest pain (lasting for
≥30 min) with the appearance of abnormal and persistent Q
or QS waves and/or elevations of cardiac enzymes. Possible
myocardial infarction was indicated by typical chest pain
without positive changes in the ECG or enzyme elevation.
Effort-associated angina pectoris was defined as repeated
episodes of chest pain during effort, especially when walk-
ing, usually disappearing rapidly after the cessation of effort
or by use of sublingual nitroglycerin. Sudden cardiac death
was defined as death within 1 h from the abrupt onset of
symptoms, unassociated with a previous diagnosis of coro-
nary heart disease, stroke, or other identified causes of death.
Definite and possible myocardial infarction, effort-associated
angina pectoris, and sudden cardiac death were combined
and presented as total coronary heart disease. Using these
standardized criteria, final diagnoses were made by a panel
of two or three study physician-epidemiologists who were
blinded to baseline risk factor data.
Population Surveys of Cardiovascular Risk Factors
Risk factors for cardiovascular disease were measured at a
baseline examination. An interviewer assessed the smoking
history and the number of cigarettes smoked per day. Ex-
smokers were defined as individuals who had quit smoking
at least 3 months previously. To assess the reliability of
smoking rate, a subsample (67%) of the baseline participants
(n＝2,435) were asked again about their smoking status at 3
to 7 years (5.1 years in average) after the baseline examina-
tion; the proportion of men who retained their same smoking
status was 82% for never-smokers, 87% for ex-smokers,
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59% for current smokers of ≤20 cigarettes per day, and 76%
for current smokers of ＞20 cigarettes per day.
We measured several potential confounders: body mass
index, arterial blood pressure, serum total cholesterol, pro-
teinuria, ethanol intake, diabetes mellitus, hypertensive oph-
thalmoscopic changes, and ECG evidence of atrial fibrilla-
tion and ischemic myocardial change. Height in stocking feet
and weight in light clothing were measured. Body mass in-
dex was calculated as weight (kg) divided by the square of
height (m2). Arterial blood pressures were measured by
trained observers using standard mercury sphygmomanome-
ters on the right arm of seated participants after a 5-min rest
(20). Hypertension was defined as systolic blood pressure of
≥160 mmHg and/or use of antihypertensive medication.
Serum total cholesterol was measured by the Liebermann-
Burchard direct method using an Autoanalyzer II (Techni-
con, Terrytown, USA) (21). The laboratory was standardized
by the Lipid Standardization Program of the Centers for Dis-
ease Control and Prevention in Atlanta, USA and successfully
met the criteria of precision and accuracy of cholesterol mea-
surements (22). Urine was analyzed for proteinuria (positive:
≥＋) with Uristix (Ames Co., Elkhart, USA). An inter-
view was conducted to determine the usual weekly intake of
ethanol in go units (a Japanese traditional unit of volume
corresponding to 23 g ethanol), which was converted to 
g of ethanol per day. Ex-drinkers were defined as men 
who had quit drinking at least 3 months previously. Diabetes
mellitus was defined as fasting glucose of ≥7.0 mmol/l, or a
non-fasting glucose of ≥11.1 mmol/l, and/or use of medica-
tion for diabetes.
To estimate athero-arteriosclerotic end-organ damages, a
color photograph of the right ocular fundus was taken and
coded according to Scheie’s classification (23). Grades II or
higher hypertensive or arteriosclerotic changes in the retinal
arterioles were regarded as significant changes. Reliable
photographs for grading were obtained in 90% of the partici-
pants; most of the remaining cases had cataract and were re-
garded as missing data. A resting ECG was obtained in the
supine position and coded according to the Minnesota Code,
second version (19). We regarded Minnesota Codes atrial
fibrillation (8-3-1) and atrial flutter (8-3-2) as atrial fibrilla-
tion, and ST-T changes (4-1 to 4-3 or 5-1 to 5-3) as ischemic
myocardial changes.
Statistical Analysis
Incidence rates per 1,000 person years were calculated ac-
cording to the four smoking-status categories: never-smok-
ers, ex-smokers, current smokers of ≤20 cigarettes per day,
and current smokers of ＞20 cigarettes per day. Differences
in age-adjusted mean values and the prevalence of potential
confounding factors among the four smoking-status cate-
gories were tested by an analysis of covariance and χ2
test, respectively. When the overall difference was 
significant ( p＜0.05), comparison of confounding factors
between never-smokers and the other smoking categories
was made using a Student’s t-test or χ2 test. The relative 
risk (RR) and 95% confidence interval (CI) relative to 
never-smokers were calculated after adjusting for age and
other potential confounding factors using the Cox propor-
tional hazards model. The proportionality was tested and ac-
cepted for each model. Potential confounding factors were
age (years), systolic blood pressure levels (mmHg), antihy-
pertensive medication use (yes vs. no), serum total choles-
terol category (＜4.14, 4.14–4.65, 4.65–5.17, 5.17–5.69 and
≥5.69 mmol/l), quartiles of sex-specific body mass index
(kg/m2), proteinuria (positive vs. negative), diabetes mellitus
(yes vs. no), hypertensive and/or arteriosclerotic ophthalmo-
scopic changes (yes vs. no), atrial fibrillation (yes vs. no), is-
chemic myocardial changes (yes vs. no), ethanol intake cate-
gory (non-current drinkers, current drinkers of ＜23, 23–46,
46–69, ≥69 g/day), and community. We used dummy vari-
ables for the covariates in the multivariate analyses, with the
exception of age and systolic blood pressure levels, which
were continuous variable. The relation between smoking and
risk of total stroke was examined further after stratification
by the two hypertension subgroups (systolic blood pressure
＜160 mmHg free from antihypertensive medication, and
≥160 mmHg or using antihypertensive medication). The
stratified analysis was not conducted for coronary heart dis-
ease because of the small number of cases among never-
smokers. Because the relation between smoking and cardio-
vascular disease was similar among the three surveyed popu-
lations, we presented the results of the combined cohorts ad-
justed for community. The population-attributable fraction
was calculated by P×(1－1/RR), where P represents the
prevalence of smokers among cases. The formula of Green-
land was used for calculation of the 95% CI (24).
Results
During the 14.3-year follow-up, there were 257 incident
strokes and 100 coronary heart disease events. The total
number of cases of cardiovascular disease was 345, since 12
cases suffered from both stroke and coronary heart disease.
There were 50 intraparenchymal hemorrhages, 25 subarach-
noid hemorrhages, 173 ischemic strokes and 9 unclassified
strokes. Among the coronary heart disease events, there were
64 myocardial infarctions, 24 effort-associated angina pec-
toris and 12 sudden cardiac deaths.
To examine confounders for smoking-disease associa-
tions, mean age and age-adjusted values of selected risk fac-
tors at baseline were compared among smoking categories
(Table 1). Ex-smokers and smokers of ≤20 cigarettes per day
were 1 to 2 years older than never-smokers. Mean systolic
blood pressure and the prevalence of hypertension were
higher in smokers of ＞20 cigarettes per day than in never-
smokers, but such a difference was not found for mean dia-
stolic blood pressure or the prevalence of antihypertensive
medication use. Mean serum total cholesterol levels were
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higher in ex-smokers, and lower in smokers of ＞20 ciga-
rettes per day than in never-smokers. Mean body mass index
was lower in current smokers than in never-smokers. The
prevalence of proteinuria and diabetes mellitus did not vary
among smoking categories. The prevalence of atrial fibrilla-
tion and ST-T changes on ECG was higher in ex-smokers
than in never-smokers. The prevalence of hypertensive
and/or arteriosclerotic ophthalmoscopic changes was lower
in ex-smokers and smokers of ≤20 cigarettes per day than in
never-smokers. Mean ethanol intake was higher in current
smokers than in never-smokers, while the prevalence of ex-
drinkers was higher in ex-smokers and was lower in current
smokers of＞20 cigarettes per day than in never-smokers.
The age and community-adjusted RR of total strokes was
1.9 (95% CI, 1.3–2.7) for smokers of ＞20 cigarettes per day
compared with never smokers, and the trend remained statis-
tically significant after adjustment for cardiovascular risk
factors (Table 2). The respective age and community-adjust-
ed RR of hemorrhagic stroke was 2.2 (1.1–4.4), but the asso-
ciation was no longer statistically significant after further ad-
justment for cardiovascular risk factors. The respective age
and community-adjusted RR of ischemic stroke was 1.7
(1.1–2.8) and remained of borderline significance ( p＝0.07)
after further adjustment for cardiovascular risk factors. The
age and community-adjusted RR for smokers of ＞20 ciga-
rettes per day was 1.9 (0.8–4.2) for intraparenchymal hemor-
rhage, 3.2 (0.7–14.1) for subarachnoid hemorrhage, 1.6
(0.8–3.3) for lacunar stroke and 1.9 (0.5–6.8) for large-artery
occlusive stroke; none of these values reached the level of
statistical significance, probably due to the small number of
cases.
The age and community-adjusted RRs of coronary heart
disease relative to never-smokers were 4.2 (1.4–12.6) for ex-
smokers, 4.2 (1.5–12.1) for smokers of ≤20 cigarettes per
day, and 4.5 (1.6–12.6) for smokers of ＞20 cigarettes per
day. These relations did not change substantially after further
adjustment for cardiovascular risk factors. The age and com-
munity-adjusted and multivariate RRs of total cardiovascular
disease for smokers of ＞20 cigarettes per day were 2.1
(1.5–3.0) and 1.9 (1.3–2.7), respectively. Ex-smokers had no
excess risk of total cardiovascular disease.
Table 3 provides multivariate RRs of total and ischemic
strokes according to two subgroups of hypertension status.
The data for coronary heart disease are not presented be-
cause the number of cases was not large enough for the strat-
ification analysis. The excess risk of total stroke associated
with current smoking of ＞20 cigarettes per day was ob-
served primarily among hypertensive men. We also observed
an excess risk of ischemic stroke among hypertensive men
who smoked ＞20 cigarettes per day (RR＝2.2 (1.0–5.0),
p＝0.045).
Because some of the previous studies used combined data
on never and ex-smokers, we also combined these groups in
our analysis in order to facilitate a more direct comparison
among studies. The multivariate RRs of smokers of ＞20
cigarettes per day were 1.8 (1.3–2.5) for total stroke, 1.6
(0.8–3.4) for intraparenchymal hemorrhage, 3.1 (0.9–11.0)
for subarachnoid hemorrhage, 1.7 (1.2–2.5) for ischemic
stroke, 2.0 (1.1–3.6) for lacunar infarction, and 1.9 (0.7–5.0)
for large-artery occlusive infarction, and 1.8 (1.1–3.1) for
coronary heart disease (not shown in the table).
To estimate the impact of any current cigarette smoking
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Table 1. Age-Adjusted Mean Values of Prevalence (%) or Risk Factors at Baseline According to Smoking Status in 3,626 Men
Aged 40–69 Years
Never-smokers Ex-smokers
Current smokers
1–20/day ＞20/day
Number 531 599 951 1,545
Age (years) 52 54＊＊＊ 53＊＊ 52
Systolic blood pressure (mmHg) 136 135 137 139＊＊
Diastolic blood pressure (mmHg) 83 82 82 83
Use of antihypertensive medication (%) 14 13 13 13
Hypertension† (%) 21 19 22 25＊
Serum total cholesterol (mmol/l) 4.79 4.91＊ 4.73 4.69＊
Body mass index (kg/m2) 23.6 23.4 22.5＊＊＊ 22.8＊＊＊
Proteinuria (%) 4 3 5 6
Diabetes mellitus (%) 3 2 3 3
Atrial fibrillation on ECG (%) 1 2＊ 1 1
ST-T change on ECG (%) 3 6＊ 6＊ 4
Hypertensive and/or arteriosclerotic fundal changes (%) 23 13＊＊＊ 16＊＊ 19
Alcohol intake (g/day) 23 21 28＊＊ 33＊＊＊
Ex-drinkers (%) 24 30＊ 21 18＊＊
†Hypertension was defined as systolic blood pressure of ≧160 mmHg and/or use of antihypertensive medication. ＊p＜0.05, 
＊＊p＜0.01, ＊＊＊p＜0.001, compared with never smokers.
on cardiovascular disease, we calculated the population-at-
tributable fraction by combining the data on never and ex-
smokers. The population attributable fraction associated with
current smoking was 28 (95% CI, 9–43) % for total stroke,
33 (3–54) % for coronary heart disease and 31 (15–44) % for
total cardiovascular diseases (data not shown).
Discussion
The present study confirmed that, in Japanese men, smoking
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Table 2. Age, Community-Adjusted and Multivariate RRs of Stroke and Coronary Heart Disease According to Smoking
Status in 3,626 Men Aged 40–69 Years
Cardiovascular disease Never-smokers Ex-smokers
Current smokers
1–20/day ＞20/day
Person years for stroke 8,361 8,241 13,366 22,472
Total stroke (n＝257)
Number of cases 32 26 57 142
Age and community-adjusted RR 1.0 0.9 (0.5–1.5) 1.2 (0.8–1.8) 1.9 (1.3–2.7)
Multivariate RR† 1.0 0.8 (0.5–1.3) 1.1 (0.7–1.7) 1.6 (1.1–2.4)
Hemorrhagic stroke (n＝75)
Number of cases 9 4 13 49
Age and community-adjusted RR 1.0 0.5 (0.1–2.2) 0.9 (0.4–2.2) 2.2 (1.1–4.4)
Multivariate RR† 1.0 0.5 (0.2–1.8) 0.7 (0.3–1.8) 1.5 (0.7–3.2)
Intraparenchymal hemorrhage (n＝50)
Number of cases 7 3 8 32
Age and community-adjusted RR 1.0 0.5 (0.1–1.9) 0.8 (0.3–2.1) 1.9 (0.8–4.2)
Multivariate RR† 1.0 0.5 (0.1–2.2) 0.6 (0.2–1.7) 1.3 (0.5–3.1)
Subarachnoid hemorrhage (n＝25)
Number of cases 2 1 5 17
Age and community-adjusted RR 1.0 — 1.6 (0.3–8.2) 3.2 (0.7–14.1)
Multivariate RR† 1.0 — 1.2 (0.2–6.3) 2.4 (0.5–10.7)
Ischemic stroke (n＝173)
Number of cases 22 21 42 88
Age and community-adjusted RR 1.0 1.1 (0.6–2.0) 1.3 (0.8–2.2) 1.7 (1.1–2.8)
Multivariate RR† 1.0 0.8 (0.4–1.6) 1.2 (0.7–2.1) 1.6 (1.0–2.5)
Lacunar infarction (n＝70)
Number of cases 10 6 13 41
Age and community-adjusted RR 1.0 0.6 (0.2–1.7) 0.8 (0.4–1.9) 1.6 (0.8–3.3)
Multivariate RR† 1.0 0.5 (0.2–1.5) 0.7 (0.3–1.7) 1.5 (0.7–3.0)
Large-artery occlusive infarction (n＝23)
Number of cases 3 4 2 14
Age and community-adjusted RR 1.0 1.3 (0.3–6.2) 0.4 (0.1–2.6) 1.9 (0.5–6.8)
Multivariate RR† 1.0 1.3 (0.3–6.3) 0.5 (0.1–3.0) 2.2 (0.6–8.0)
Person years for coronary heart disease 8,554 8,276 13,518 23,003
Coronary heart disease (n＝100)
Number of cases 4 19 29 48
Age and community-adjusted RR 1.0 4.2 (1.4–12.6) 4.2 (1.5–12.1) 4.5 (1.6–12.6)
Multivariate RR† 1.0 3.7 (1.2–11.2) 4.1 (1.4–11.8) 4.6 (1.6–12.9)
Person years for total cardiovascular disease 8,336 8,164 13,367 22,270
Total cardiovascular disease (n＝345)
Number of cases 36 41 83 185
Age and community-adjusted RR 1.0 1.2 (0.7–1.9) 1.5 (1.0–2.2) 2.1 (1.5–3.0)
Multivariate RR† 1.0 1.0 (0.6–1.6) 1.4 (0.9–2.0) 1.9 (1.3–2.7)
†Adjusted for age, systolic blood pressure levels, antihypertensive medication use, serum total cholesterol category, body mass index,
proteinuria, diabetes mellitus, atrial fibrillation, ST-T changes, fundus changes, ethanol intake and community. RR, relative risk.
＞20 cigarettes per day is a significant risk factor for both to-
tal stroke and coronary heart disease in comparison with
nonsmoking. An excess risk for ischemic stroke was of bor-
derline statistical significance after adjustment for known
cardiovascular risk factors. We found the excess risk of total
and ischemic strokes associated with current smoking of 
＞20 cigarettes per day primarily among hypertensive men.
Hypertension may have a synergetic effect with smoking on
risk of total stroke among Japanese men. This finding was
supported by the Hisayama study, which found that current
smoking tended to raise the risk of non-embolic cerebral in-
farction among hypertensive men, but not non-hypertensive
men (4). However, the Framingham study (25) and the 
Nurses’ Health study (26) showed that the smoking-stroke
association was similar between hypertensives and non-hy-
pertensives.
A positive association between smoking and risks of total
and ischemic strokes has been consistently reported in West-
ern countries. According to a meta-analysis of 32 observa-
tional studies mostly among Caucasians, the pooled RRs
were 1.5 (95% CI, 1.3–1.6) for total stroke and 1.9 (1.7–2.2)
for ischemic stroke (27). However, in Japanese, the relation
between smoking and risk of ischemic stroke has been weak
and inconsistent (7–10, 28–30). The Shibata study, a 15.5-
year follow-up study of Japanese men (n＝961), showed a
positive relationship between smoking and risk of ischemic
stroke (multivariate RR for smoking of ≥20 cigarettes vs. 
＜20 cigarettes per day＝2.8 (95% CI, 1.3–6.2)) (31), but a
20.0-year follow-up of the same cohort showed no signifi-
cant association (32). The Hisayama study, a 32-year follow-
up study of 707 Japanese men, reported no significant asso-
ciation between smoking and total, hemorrhagic or ischemic
strokes, but did report a two-fold higher risk of lacunar in-
farction among male current smokers than among non-cur-
rent smokers (33). That study, however, did not discriminate
between ex-smokers and never-smokers, but rather com-
bined these two categories as a referent group. In the present
study, when we similarly grouped ex- and never-smokers as
non-current smokers, there was a comparable excess risk of
lacunar infarction; the multivariate RR was 2.0 (1.1–3.6) for
smokers of ＞20 cigarettes per day.
The reasons for the inconsistent association between
smoking and risk of ischemic stroke in Japanese populations
are not clear. One possible explanation is that there is a high-
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Table 3. Multivariate RRs of Total and Ischemic Strokes According to Smoking Stratified by Hypertension Status in 3,626
Men Aged 40–69 Years
Never-smokers Ex-smokers
Current smokers
1–20/day ＞20/day
Total stroke
Non-hypertensives
Person years 6,631 6,571 10,683 17,513
Number at risk 422 0,474 00,739 01,168
Number of cases 20 0,013 00,026 00,067
Multivariate RR† 1.0 0.5 (0.3–1.1) 0.7 (0.4–1.3) 1.2 (0.7–2.0)
Hypertensives
Person years 1,730 1,670 02,684 04,959
Number at risk 109 0,125 00,212 00,377
Number of cases 12 0,013 00,031 00,075
Multivariate RR† 1.0 1.2 (0.5–2.8) 1.6 (0.8–3.2) 2.3 (1.2–4.4)
Ischemic stroke
Non-hypertensives
Person years 6,631 6,571 10,683 17,513
Number at risk 422 0,474 00,739 01,168
Number of cases 14 0,008 00,018 00,044
Multivariate RR† 1.0 0.5 (0.2–1.2) 0.7 (0.4–1.5) 1.3 (0.7–2.4)
Hypertensives
Person years 1,730 1,670 02,684 04,959
Number at risk 109 0,125 00,212 00,377
Number of cases 8 0,013 00,024 00,044
Multivariate RR† 1.0 1.4 (0.5–3.7) 1.9 (0.8–4.3) 2.2 (1.0–5.0)
Non-hypertensives were defined as having systolic blood pressure ＜160 mmHg and free of antihypertensive medication; hyperten-
sives were defined as having systolic blood pressure ≥160 mmHg and/or use of antihypertensive medication. †Adjusted for age, sys-
tolic blood pressure levels, antihypertensive medication use, serum total cholesterol category, body mass index, proteinuria, diabetes
mellitus, atrial fibrillation, ST-T changes, fundus changes, ethanol intake and community. RR, relative risk.
er proportion of lacunar infarctions among ischemic strokes
in Japanese (30–40%) than in Caucasians (15%) (34), since
previous studies have shown that smoking was less strongly
associated with risk of lacunar infarction than large-artery
occlusive infarction (15, 35). The Nurses’ Health study (15)
showed the multivariate RR of large-artery occlusive infarc-
tion of current smoking compared with never smoking was
3.4 (2.2–5.0), whereas that of lacunar infarction was 2.8
(2.0–3.9). A retrospective study in Taiwan (35) showed that
the prevalence of smoking was significantly higher among
patients with large-artery occlusive infarction (42%) than
among those with lacunar infarction (29%). In the present
study, the RRs (95% CI) for large-artery occlusive infarction
and lacunar infarction were 1.9 (0.5–6.8) and 1.6 (0.8–3.3),
respectively, and probably failed to reach the level of statisti-
cal significance due to the small number of cases. Smoking
causes atherosclerosis of the large cerebral arteries (36) and
carotid arteries (37) probably due to direct injury of endothe-
lial cells (38), atheroma formation through low high-density
lipoprotein (HDL)-cholesterol levels (39), and acceleration
of thrombus formation through increased plasma fibrinogen
(40), increased platelet aggregability (41) and decreased 
fibrinolytic activity (42). Another possibility is that non-
smokers may be heavily exposed to environmental tobacco
smoke, and this exposure may weaken the associations be-
tween active smoking and risk of ischemic stroke. Our previ-
ous study showed that environmental tobacco smoke was as-
sociated with increased plasma fibrinogen levels (43), one of
the risk factors for ischemic stroke (44). However, the infor-
mation on the relation between environmental tobacco
smoke and risk of ischemic stroke is limited (45).
In the present study, the excess risk of subarachnoid hem-
orrhage associated with smoking did not reach statistical sig-
nificance probably due to the small number of cases. We pre-
viously reported that current smokers had a significantly
higher risk of subarachnoid hemorrhage compared with nev-
er-smokers among Japanese women, but not among Japanese
men (46). A positive relation between smoking and sub-
arachnoid hemorrhage has been consistently reported in pre-
vious studies of Caucasians and Japanese Americans (27).
The mechanism is not clear, but there are some lines of evi-
dence which suggest that smoking increases hemodynamic
stress on the Circle of Willis (47) through enhanced athero-
sclerosis in the carotid and basal cerebral arteries, as well as
through increased release of proteinases from activated pul-
monary macrophages, which enhance the fragility of cere-
bral aneurysms (48).
Our results showed that the risk of coronary heart disease
was four times higher in current smokers than in never-
smokers, which was consistent with previous reports on Cau-
casian populations (49) and Japanese populations (2–6). The
impact of cigarette smoking on the development of coronary
heart disease may be similar to that of large-artery occlusive
infarction (36–42), but there are other mechanisms, includ-
ing coronary artery spasm (50) and cardiac arrhythmia (51),
which are enhanced by smoking.
The estimate of population-attributable fraction suggests
that approximately one-fourth of total strokes were attribut-
able to smoking. Previous studies have reported that 12% to
49% of strokes might be attributable to smoking among Cau-
casians (52, 53), and that 27% of strokes might be attribut-
able to smoking among Japanese men aged 40–64 (32), in
agreement with the results of the present study. Therefore,
smoking cessation may still be effective in preventing stroke
among Japanese men.
As for the limitations of the present study, a single mea-
surement for smoking status may weaken the associations
due to regression dilution bias, since the prevalence of smok-
ing declined from 66% to 60% during the 5 years after base-
line measurement. We estimated that the regression dilution
rate (54) was 0.79, and thus RRs after adjustment for the re-
gression dilution effect should be 30% higher than those re-
ported in the present study.
In conclusion, current smoking of ＞20 cigarettes per day
increased the risk of total and ischemic strokes and coronary
heart disease among Japanese middle-aged men. The excess
risk of total and ischemic strokes associated with smoking
was evident primarily among hypertensive men. Our study
also suggests that smoking cessation may contribute to a re-
duced risk of total stroke.
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